Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 17 Ovarian Neoplasms 11 Neoplasms 8 Fallopian Tube Neoplasms 8 Triple Negative Breast Neoplasms 7 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Pancreatic Neoplasms 4 Endometrial Neoplasms 4 Neuroendocrine Tumors 3 Glioma 3 Glioblastoma 3 Carcinoma, Ovarian Epithelial 3 Recurrence 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Fanconi Anemia, Complementation Group D1 2 Cholangiocarcinoma 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 SCLC,Extensive Stage 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Platinum-sensitive Ovarian Cancer 1

Interventions

pembrolizumab 6 cabozantinib 6 Nivolumab 5 Ipilimumab 5 Axitinib 5 Radiosurgery 3 Blood Specimen Collection 3 zimberelimab 2 lenvatinib 2 Ultrasonography 2 Radiotherapy 2 Biopsy 2 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 palbociclib 1 orellanine 1 olaparib 1 gallium Ga 68 dotatate 1 fludarabine 1 cyclopropapyrroloindole 1 brodalumab 1 belzutifan 1 atezolizumab 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Therapeutics 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × olaparib × Clear all

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡